Xencor | Kontanter Og Tilsvarende



Cash And Equivalent Lave om Dato
AbbVie USD 5.52B 1.73B 2024-12
Alnylam Pharmaceuticals USD 966.43M 133.49M 2024-12
Amgen USD 11.97B 2.96B 2024-12
Arrowhead Research USD 51.79M 47.4M 2024-12
AstraZeneca USD 5.49B 691M 2024-12
Biogen USD 2.38B 675.8M 2024-12
Bristol-Myers Squibb USD 10.35B 2.46B 2024-12
Cytokinetics USD 94.86M 47.97M 2024-12
GlaxoSmithKline GBP 3.87B 678M 2024-12
J&J USD 6.12B 1.28B 2024-12
MacroGenics USD 179.62M 95.69M 2024-09
Merck USD 13.24B 1.35B 2024-12
Novartis USD 8.87B 4.74B 2024-12
Pfizer USD 1.04B 49M 2024-12
Regeneron Pharmaceuticals USD 17.91B 15.9B 2024-12
Roche Holding CHF 6.98B 2.15B 2024-12
Xencor USD 40.88M 11.84M 2024-12



Xencor Kontanter Og Tilsvarende - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.